Members of the National Institute of Allergy and Infectious Diseases, the National Institute of Oncology and the University of Maryland School of Medicine also participated in the study. The results of the work were published in the scientific journal Research Square.
The article states that scientists performed autopsies on 44 patients with COVID-19. It turned out that the SARS-CoV-2 coronavirus had spread widely in the body even of those patients who had a mild form of the disease.
In Italy, they said that the effectiveness of vaccination against covid decreases by 40% after five months
Experts have found the RNA of the virus in several areas of the brain. Moreover, traces of coronavirus were observed 230 days after the first appearance of symptoms. The researchers concluded that the virus can multiply and infect human cells outside the respiratory system. However, it practically does not cause inflammation outside the lungs, the authors of the article stated.
“Our data prove that SARS-CoV-2 causes systemic infection and can persist in the body for several months,” the article says.
Earlier, Doctor of Medical Sciences Anatoly Altstein said that death from COVID-19 can occur 3-4 weeks after infection. At the same time, according to the expert, you should not worry about the possible transmission of the virus to mice and other rodents, since animals do not participate in maintaining the epidemic.
The “secret” told that the Ministry of Health of Russia has registered a drug for the treatment of coronavirus “Mir-19”. It was developed by the Federal Medical and Biological Agency (FMBA). The Institute of Immunology, which was part of the FMBA, received a patent for the drug in April. The medicine is suitable for the prevention and treatment of COVID-19, it is a nasal spray or an inhalation liquid.
Irina Meshcherskaya